Insulet (PODD) FY2017 results: revenue $464 million, up 26.4% on the year
Insulet Corp. (PODD) reported revenue of $464 million for fiscal 2017, the year ended 31 December 2017, up 26.4% on the year before. Net income was -$27 million, and diluted earnings per share $-0.46. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2018.
Revenue
$464 million
+26.4% on the year
FY2010FY2017
Operating margin
-1.6%
-2.9% a year earlier
FY2010FY2017
Net income
-$27 million
FY2010FY2017
Diluted EPS
-$0.46
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
464
367
264
+26.4%
Cost of revenue
187
156
131
+19.7%
Gross profit
277
211
133
+31.3%
Gross margin
59.8%
57.5%
50.5%
Research and development
75.7
55.7
43.2
+35.9%
Operating income
-7.4
-10.7
-48.7
Operating margin
-1.6%
-2.9%
-18.5%
Interest expense
21.2
14.4
12.7
+47.4%
Pre-tax income
-26.6
-26.8
-61.4
Income tax
0.2
0.4
0.2
-49.0%
Net income
-26.8
-28.9
-73.5
Net margin
-5.8%
-7.9%
-27.9%
Diluted EPS
-$0.46
-$0.48
-$1.29
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
41.3
15.9
-12.6
+159.6%
Capital expenditure
73.8
22.1
10.6
+233.7%
Free cash flow
-32.5
-6.2
-23.2
Free cash flow margin
-7.0%
-1.7%
-8.8%
Cash from investing
-211
-178
-15.3
Cash from financing
305
177
-0.4
+72.5%
Depreciation and amortisation
13.9
13.8
15.8
+0.5%
Share-based compensation
31.9
23.6
19.2
+35.2%
Diluted shares, weighted
58m
57m
n/a
+1.3%
Shares outstanding at period end
58m
57m
57m
+1.5%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
159
63.1
34.1
+151.0%
Debt
566
333
172
+70.1%
Other liabilities
92.1
60.7
69.4
+51.6%
Total liabilities and equity
817
457
275
+78.9%
Fixed assets
108
44.8
41.8
+141.0%
Goodwill
39.8
39.7
39.6
+0.4%
Intangible assets
4.4
2.0
0.9
+113.2%
Investments
293
161
0.0
+81.6%
Cash and equivalents
273
137
123
+98.7%
Receivables
53.4
28.8
42.5
+85.3%
Inventory
33.8
35.5
12.0
-4.8%
Other assets
11.9
7.3
15.6
+63.5%
Total assets
817
457
275
+78.9%
10-K for the year ended 31 December 2017, filed 22 February 2018: the filing.